These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38293793)

  • 1. Features of cardiovascular magnetic resonance native T1 mapping in maintenance hemodialysis patients and their related factors.
    Zhang C; Yao L; Liu M; Zhou Y
    Ren Fail; 2024 Dec; 46(1):2310078. PubMed ID: 38293793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
    Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction.
    Han X; He F; Cao Y; Li Y; Gu J; Shi H
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2265-2278. PubMed ID: 32686028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal myocardial native T
    Burkhardt BEU; Menghini C; Rücker B; Kellenberger CJ; Valsangiacomo Buechel ER
    J Magn Reson Imaging; 2020 Mar; 51(3):897-903. PubMed ID: 31507010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.
    Graham-Brown MP; Rutherford E; Levelt E; March DS; Churchward DR; Stensel DJ; McComb C; Mangion K; Cockburn S; Berry C; Moon JC; Mark PB; Burton JO; McCann GP
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):21. PubMed ID: 28238284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Graham-Brown MP; March DS; Churchward DR; Stensel DJ; Singh A; Arnold R; Burton JO; McCann GP
    Kidney Int; 2016 Oct; 90(4):835-44. PubMed ID: 27633869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.
    Cao Y; Zeng W; Cui Y; Kong X; Wang M; Yu J; Zhang S; Song J; Yan X; Greiser A; Shi H
    Cardiovasc Diabetol; 2018 Jan; 17(1):7. PubMed ID: 29301529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot.
    Yim D; Riesenkampff E; Caro-Dominguez P; Yoo SJ; Seed M; Grosse-Wortmann L
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal.
    Rankin AJ; Mangion K; Lees JS; Rutherford E; Gillis KA; Edy E; Dymock L; Treibel TA; Radjenovic A; Patel RK; Berry C; Roditi G; Mark PB
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):125. PubMed ID: 34758850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
    Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of myocardial involvement by T
    Yu L; Sun J; Sun J; Li J; Dong Y; Zhou X; Greiser A; Han Y; Zhang Q; Xie Q; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):415-422. PubMed ID: 29328539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Value of Native T1 Mapping in Symptomatic Adults with Congenital Heart Disease: A Preliminary Study of 3.0 Tesla Cardiac Magnetic Resonance Imaging.
    Shiina Y; Inai K; Taniguchi K; Takahashi T; Nagao M
    Pediatr Cardiol; 2020 Jan; 41(1):94-100. PubMed ID: 31654097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis.
    Lee SP; Lee W; Lee JM; Park EA; Kim HK; Kim YJ; Sohn DW
    Radiology; 2015 Feb; 274(2):359-69. PubMed ID: 25251584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference values of myocardial structure, function, and tissue composition by cardiac magnetic resonance in healthy African-Americans at 3T and their relations to serologic and cardiovascular risk factors.
    Liu CY; Bluemke DA; Gerstenblith G; Zimmerman SL; Li J; Zhu H; Lai S; Lai H
    Am J Cardiol; 2014 Sep; 114(5):789-795. PubMed ID: 25037675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis.
    Backhaus SJ; Lange T; Beuthner BE; Topci R; Wang X; Kowallick JT; Lotz J; Seidler T; Toischer K; Zeisberg EM; Puls M; Jacobshagen C; Uecker M; Hasenfuß G; Schuster A
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):46. PubMed ID: 32564773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients.
    Qin L; Gu S; Xiao R; Liu P; Yan F; Yu H; Yang W
    Eur Radiol; 2022 Oct; 32(10):6878-6890. PubMed ID: 35554644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.